Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2001
VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptorM Kuzuya, M A Ramos, S Kanda, et al.
Cancer Research|October 28, 1999
Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibodyK Nakamura, M Hanibuchi, S Yano, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1987
Expression of the T-cell receptor gamma-chain gene products on the surface of peripheral T cells and T-cell blasts generated by allogeneic mixed lymphocyte reactionK Maeda, N Nakanishi, B L Rogers, et al.
ESMO Open|February 25, 2026
Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studiesK Shitara, E Smyth, F Lordick, et al.
British Journal of Cancer|February 3, 2011
BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancerT Yokota, T Ura, N Shibata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2010
Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxelK Shitara, K Matsuo, D Takahari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2011
Genetic polymorphism of IGF-I predicts recurrence in patients with gastric cancer who have undergone curative gastrectomyK Shitara, S Ito, K Misawa, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
DESTINY-Gastric05 phase III trial of first-line trastuzumab deruxtecan, chemotherapy, and pembrolizumab in HER2-positive gastric or gastroesophageal junction cancerY Y Janjigian, E Smyth, L Shen, et al.
Bone Marrow Transplantation|August 6, 2003
Serum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantationC Ito, H Sato, K Ando, et al.
ESMO Open|January 7, 2023
Comprehensive clinical and molecular characterization of claudin 18.2 expression in advanced gastric or gastroesophageal junction cancerY Kubota, A Kawazoe, S Mishima, et al.
Pageof 8